Publication | Closed Access

Relationship of drug metabolizing enzyme genotype to plasma levels as well as myelotoxicity of cyclophosphamide in breast cancer patients

Breast OncologyOncologyBreast Cancer PatientsPlasma LevelsMedicinePathologyEnzyme GenotypeBreast CancerPharmacotherapyAnti-cancer AgentMetabolomicsPharmacologyPharmacokineticsCancer ResearchDrug Discovery